We are live on ! Find out more
INDP icon

Indaptus Therapeutics
INDP

47 hedge funds and large institutions have $49.4M invested in Indaptus Therapeutics in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 5

56% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 9

31% more funds holding

Funds holding: 36 → 47 (+11)

39% less capital invested

Capital invested by funds: $80.9M → $49.4M (-$31.6M)

90% less call options, than puts

Call options by funds: $303K | Put options by funds: $3M

Holders
47
Holders Change
+11
Holders Change %
+30.56%
% of All Funds
1.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
14
Reduced
9
Closed
5
Calls
$303K
Puts
$3M
Net Calls
-$2.7M
Net Calls Change
-$2.92M

Top Buyers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
+$3.49M
2
HIIFS
Harel Insurance Investments & Financial Services
Israel
+$3.28M
3
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
+$3.28M
4
PM
Prosight Management
Texas
+$1.54M
5
MIFH
Migdal Insurance & Financial Holdings
Israel
+$845K

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$9.46M
2
MIH
Meitav Investment House
Israel
-$1.66M
3
6CM
683 Capital Management
New York
-$1.1M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$984K
5
EIM
Essex Investment Management
Massachusetts
-$479K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$125K +$164K +13 New
Geode Capital Management
27
Geode Capital Management
Massachusetts
$117K +$50.5K +4 +50%
Simplex Trading
28
Simplex Trading
Illinois
$113K -$303K -24 -67%
Dimensional Fund Advisors
29
Dimensional Fund Advisors
Texas
$108K – – –
SPC
30
Sigma Planning Corp
Michigan
$80K -$37.8K -3 -27%
Group One Trading
31
Group One Trading
Illinois
$68K – – –
Two Sigma Advisers
32
Two Sigma Advisers
New York
$67K +$88.3K +7 New
Goldman Sachs
33
Goldman Sachs
New York
$62K +$75.7K +6 New
LI
34
Leap Investments
Illinois
$60K +$75.7K +6 New
Barclays
35
Barclays
United Kingdom
$49K +$63.1K +5 New
KWM
36
Kingsview Wealth Management
Oregon
$47K +$63.1K +5 New
AS
37
Altshuler Shaham
Israel
$27K – – –
TRCT
38
Tower Research Capital (TRC)
New York
$26K +$37.8K +3 New
RFA
39
Reilly Financial Advisors
California
$22K – – –
FANJ
40
Financial Architects (New Jersey)
New Jersey
$20K – – –
CI
41
Cowen Inc
New York
$20K +$25.2K +2 New
SPIA
42
Steward Partners Investment Advisory
New York
$19K +$25.2K +2 New
RE
43
RBC Europe
United Kingdom
$13.3K – – –
CG
44
Cutler Group
California
$11K – – –
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$10K +$12.6K +1 New
BlackRock
46
BlackRock
New York
$8K +$12.6K +1 New
UBS Group
47
UBS Group
Switzerland
$5K -$214K -17 -94%
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$4K – – –
EDRH
49
Edmond de Rothschild Holding
Switzerland
$3K – – –
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
– -$984K -78 Closed
1
2
3

INDP Hedge Fund Activity: Q2 2019 in Review

47 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q2 2019, worth a combined $49.4M — down 39% from $80.9M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new INDP positions and 5 closed out — a net gain of 11 holders — while 14 added to existing stakes and 9 trimmed.

The largest buyer was Sphera Funds Management, opening a new position worth an estimated $3.49M. The largest seller was Avoro Capital Advisors, cutting an estimated $9.46M.

  • 47 institutional investors held Indaptus Therapeutics (INDP) as of Q2 2019, up from 36 in Q1 2019.
  • Funds reported $49.4M of Indaptus Therapeutics stock for Q2 2019, down 39% quarter-over-quarter.
  • 16 funds opened new Indaptus Therapeutics positions in Q2 2019 and 5 closed out, a net change of +11 holders.
  • The largest Indaptus Therapeutics buyer in Q2 2019 was Sphera Funds Management, an estimated $3.49M added.
  • The largest Indaptus Therapeutics seller in Q2 2019 was Avoro Capital Advisors, an estimated $9.46M sold.

Based on aggregated 13F filings for Q2 2019.